GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » Debt-to-Revenue

CH Biotech R&D Co (TPE:6534) Debt-to-Revenue : 0.68 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is CH Biotech R&D Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

CH Biotech R&D Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$422 Mil. CH Biotech R&D Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$326 Mil. CH Biotech R&D Co's annualized Revenue for the quarter that ended in Dec. 2024 was NT$1,102 Mil. CH Biotech R&D Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.68.


CH Biotech R&D Co Debt-to-Revenue Historical Data

The historical data trend for CH Biotech R&D Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CH Biotech R&D Co Debt-to-Revenue Chart

CH Biotech R&D Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.86 1.10 0.62 0.56 0.46

CH Biotech R&D Co Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.47 0.26 0.49 1.35 0.68

Competitive Comparison of CH Biotech R&D Co's Debt-to-Revenue

For the Agricultural Inputs subindustry, CH Biotech R&D Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CH Biotech R&D Co's Debt-to-Revenue Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where CH Biotech R&D Co's Debt-to-Revenue falls into.


;
;

CH Biotech R&D Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

CH Biotech R&D Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(421.606 + 325.72) / 1635.736
=0.46

CH Biotech R&D Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(421.606 + 325.72) / 1101.54
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


CH Biotech R&D Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of CH Biotech R&D Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CH Biotech R&D Co Business Description

Traded in Other Exchanges
N/A
Address
No. 89, Wenxian Road, Nantou, TWN, 54041
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, & sales of proprietary plant growth regulators & specialty micronutrient fertilizers. Its products include nutrient Efficiency Stress Reduction, Plant Growth Promotion, Crop Fruit Quality, Plant Derived Biotechnology. Geographically it generates the majority of its revenue from the United States.

CH Biotech R&D Co Headlines

No Headlines